In vivo use of ivermectin (IVR) for treatment for corona virus infected patients: a randomized controlled trial

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2020
INTERVENTION: 1:placebo;2:USE OF IVERMECTIN (IVR); CONDITION: Novel Coronavirus Pneumonia (COVID‐19) PRIMARY OUTCOME: Reduction of viral load and treating COVID‐19 infection; INCLUSION CRITERIA: 1. Adults with positive PCR for COVID‐19 (asymptomatic for the Pilot intervention); 2. Body weight more than 45kg; 3. Consent for voluntary participation.
Epistemonikos ID: 8bac86582a7274241818f5f2c7f032f3f673b214
First added on: Jun 22, 2020